Immuno Oncology R&D Update, December 2016

Immune Pharmaceuticals is excited to share with you our latest news concerning immuno oncology. We have gathered interviews, presentations, and written material to help bring you up to speed. Here is the footage from our Facebook Live interview earlier today.

In December 2016, the Immune Pharmaceuticals team traveled to the annual meeting of the American Society of Hematology (ASH)  in San Diego. This was an opportunity to learn about the latest developments in Acute Myeloid Leukemia(AML) and to hold a Scientific Advisory Board (SAB) for our AML drug, Ceplene®.  Below, you can watch interviews filmed before the SAB meeting as well as a presentation explaining the science behind Ceplene, narrated by Mark Levitt.

Dr. Daniel Teper and Dr. Monica Luchi Interviewed by John McCamant, December 2016

Dr. Kristoffer Hellstrand interviewed by John McCamant, December 2016


Ceplene Scientific Presentation with Mark Levitt